The platelet-albumin-bilirubin score in predicting hepatic failure after TACE for non-small hepatocellular carcinoma
The PALBI score is an effective tool for predicting hepatic failure after TACE in non-small HCC patients. PALBI Grade 3 indicates high risk (78.95%), suggesting preoperative liver protection therapy before TACE. PALBI outperforms ALBI and Child-Pugh scores in risk stratification.
Authors
- Yufei Ma (ORCID: https://orcid.org/0009-0000-6153-5840)
- Huatuo Huang (ORCID: https://orcid.org/0000-0003-4961-5711)
- Jiasheng Ma (ORCID: https://orcid.org/0000-0003-1621-7151)
- Jianchu Wang (ORCID: https://orcid.org/0000-0002-2421-6450)
- Wenxiang Liang (ORCID: https://orcid.org/0009-0003-8055-1688)
- Libai Lu
- Zongjiang Luo (ORCID: https://orcid.org/0000-0002-7012-7950)
- Liang Xu
- Yuan Lu (ORCID: https://orcid.org/0009-0003-5260-771X)
- Sizong Chen
- Hankun Yuan
- Jiajie Zhou
- Zhenrong Zhao
Institutions
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
Publication Details
- Journal
- Postgraduate Medicine
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1080/00325481.2025.2587342
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00